Nitrous Oxide Abuse: Clinical Outcomes, Pharmacology, Pharmacokinetics, Toxicity and Impact on Metabolism
Overview
Authors
Affiliations
The recreational use of nitrous oxide (NO), also called laughing gas, has increased significantly in recent years. In 2022, the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) recognized it as one of the most prevalent psychoactive substances used in Europe. Chronic nitrous oxide (NO) exposure can lead to various clinical manifestations. The most frequent symptoms are neurological (sensitive or motor disorders), but there are also other manifestations like psychiatric manifestations or cardiovascular disorders (thrombosis events). NO also affects various neurotransmitter systems, leading to its anesthetic, analgesic, anxiolytic and antidepressant properties. NO is very challenging to measure in biological matrices. Thus, in cases of NO intoxication, indirect biomarkers such as vitamin B12, plasma homocysteine and plasma MMA should be explored for diagnosis and assessment. Others markers, like oxidative stress markers, could be promising but need to be further investigated.
Taillefer de Laportaliere T, Redon M, Roussin A, Willemet E, Very E, Olivier J Drug Alcohol Rev. 2025; 44(3):908-912.
PMID: 39901315 PMC: 11886473. DOI: 10.1111/dar.14012.
Li W, Liu S, Yang S, Lin X, Zhang Z Transl Psychiatry. 2025; 15(1):34.
PMID: 39875366 PMC: 11775255. DOI: 10.1038/s41398-025-03257-y.
A fatal case of accidental asphyxia following nitrous oxide inhalation and alcohol consumption.
Liu H, Liang M, Yang Y, Ma J, Zhou Y, Dong H Forensic Sci Med Pathol. 2025; .
PMID: 39873889 DOI: 10.1007/s12024-025-00946-4.
Grzych G, Zerimech F, Touze B, Descamps C, Bout M, Joncquel M J Xenobiot. 2024; 14(4):1332-1342.
PMID: 39449416 PMC: 11503375. DOI: 10.3390/jox14040075.
[Life style drug laughing gas (nitrous oxide, NO) and the dependency criteria according to ICD-10].
Diesing D, Neu P Nervenarzt. 2024; .
PMID: 39311917 DOI: 10.1007/s00115-024-01736-z.